PSCA and neoplasm: In another study, CAR containing prostate stem cell antigen (PSCA) scFv fused to DAP12 CAR provided enhanced cytotoxicity of the NK cell line YTS against PSCA-positive tumor cell xenografts and resulted in complete tumor eradication in a significant proportion of treated mice [213].